2 active not recruiting. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 2 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Neurodevelopmental Disorders: new trials by email Literature Review of Neurodevelopmental Disorders trials Research Report on Neurodevelopmental Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Psilocybin for Treatment-Resistant Depression in Autism Psilocybin - Treatment Resistant Depression, Autism Spectrum Disorder | Phase 1 | Active not recruiting | Centre for Addiction and Mental Health | 18 | 2024-11-01 | 2026-10-26 |
| Safety and Efficacy of TSHA-102 in Pediatric Females With Rett Syndrome (REVEAL Pediatric Study) TSHA-102 - Rett Syndrome | Phase 1 / Phase 2 | Active not recruiting | Taysha Gene Therapies, Inc. | 6 | 2023-12-12 | 2025-10-15 |
Autism Spectrum Disorder (1) · Depressive Disorder, Treatment-Resistant (1) · Rett Syndrome (1)
Mental Disorders (2) · Child Development Disorders, Pervasive (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Depressive Disorder (1) · Genetic Diseases, Inborn (1) · Genetic Diseases, X-Linked (1) · Heredodegenerative Disorders, Nervous System (1) · Intellectual Disability (1) · Mood Disorders (1) · Nervous System Diseases (1) · Neurobehavioral Manifestations (1) · Neurologic Manifestations (1) · X-Linked Intellectual Disability (1)
Psilocybin (1)
Centre for Addiction and Mental Health (1) · Taysha Gene Therapies, Inc. (1)
Canada (2) · United Kingdom (1) · United States (1)
Hsiang-Yuan Lin, MD (1) · Laura Pisani, M.D. (1)